Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.
about
Characterization of DNA Methylation in Circulating Tumor CellsCirculating Tumor Cells: A Window Into Tumor Development and Therapeutic EffectivenessClinical application of circulating tumor cells in breast cancer: overview of the current interventional trialsProgress in circulating tumor cell capture and analysis: implications for cancer managementPotential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current EvidenceMultiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.Circulating Tumor Cells in Early-Stage Breast Cancer.International study on inter-reader variability for circulating tumor cells in breast cancerDetection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.Circulating tumor cells: from bench to bedsideCirculating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progressionCTC enumeration and characterization: moving toward personalized medicine.Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric studyA Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.Circulating tumour cells: their utility in cancer management and predicting outcomes.Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.Sampling circulating tumor cells for clinical benefits: how frequent?Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report.Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohortClinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer.Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis.Progress in using circulating tumor cell information to improve metastatic breast cancer therapyEstablishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.Detecting circulating tumor cells: current challenges and new trends.Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma.Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.Clinical utility of a circulating tumor cell assay in Merkel cell carcinomaMonitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?Clinical implications of the detection of circulating tumor cells in breast cancer patients.Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer.Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy?Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.Review: circulating tumor cells in the practice of breast cancer oncology.Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib.Circulating Tumor Cells as Cancer Biomarkers in the Clinic.
P2860
Q26778427-9C6289FA-FFA9-4C71-A308-FD4EDF4AC08DQ26827815-E8BCDA91-CF09-4741-9DD2-17A07428483DQ26827936-BC2DA53C-FE8F-48C6-A9FD-9751AF56C98AQ27025737-87A3830F-D0D5-4745-9B89-838966374437Q28075850-BF0736C1-1115-4705-B638-5598997D1DEDQ31006508-BC249D54-BC81-491E-B818-7E8BBA0619DFQ33579111-BC52D608-D458-477D-A6B6-15D5226C51CFQ33738688-FCF3D0D2-A73F-4312-8D94-ED798A100FFDQ34286198-8F6AAE71-C89A-407D-9638-7CC7FC7D4713Q34307782-5D7917F9-B04E-4758-81C3-0E369F3295F5Q34496964-C59422C9-C991-4586-9245-841A9458D355Q34577724-8F360518-EC7C-4AA1-ABCB-456AACB2BE3CQ34669169-FB6621D3-400F-4FAE-A9C8-5A473BC28C31Q35001280-E57D5E48-74C8-4903-8DE5-315DBCBE7DF4Q35076325-1875BA90-EB36-41B9-BA71-5AEA28F83FCFQ35427994-40B98220-2F6C-4AB0-95D3-B8DCD6A73D18Q35519793-EA32E180-A2A7-432E-90F1-536E26E305ADQ35807183-7EF571A1-1C11-4AFC-8CB4-0FCD3A5DFC60Q35819611-BE94ECFA-DCCF-4C03-A666-0919C6199D24Q36070763-117C63B8-12A9-4E86-925D-1DBEBC94A16AQ36072794-C05B00D6-DB6A-44A5-A9DF-64E9A717282AQ36095920-50AEBCF4-0D5A-4C22-9473-02491F7D6576Q36321612-D3181609-95F4-4711-BF48-11438FA58707Q36406697-9FC551AD-C55A-4B1F-90A1-EC5914C8726EQ36551186-BA7D493A-9552-4DE8-8094-40A2FEC0BF26Q36752761-EC4ED51B-4ACE-4CDB-9855-D80C4FAF935AQ36869787-D141CBD4-34AC-4C32-ABE0-1E036CA5C67DQ36915318-4E2539F9-0665-4E0B-9056-51639CB112FBQ36934364-B8A831D9-27CC-4A00-B4A6-4D39474FE020Q37086254-8BE33568-B402-46C6-B380-B5A969B3B266Q37090760-5825AB8A-71A3-43E6-BA09-CC711142C8DFQ37622003-E26D10D9-4DD2-416E-9068-F7670A87115CQ37716195-4580243C-F12F-41D5-9B40-A9C2626AEF01Q37980500-692D70CD-0854-47FD-A7DD-8617B08ECFACQ38070396-0F7677C5-671E-4AA6-95E9-A9E1FDC7D27FQ38508249-CBA19ADA-363A-455F-B192-38AA5FF56E01Q38547813-4BF47D45-E929-447C-9930-3276E3B82655Q38662712-C55B23AE-4B9E-4300-8F13-BD0909E88F15Q39027480-F2CEA3D5-4E25-431C-BE1B-84561797F80FQ39339875-E9BFE6E5-6ACD-4CD3-9FCF-A95E15517CE5
P2860
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Variation of circulating tumor ...... and therapeutic implications.
@en
Variation of circulating tumor ...... and therapeutic implications.
@nl
type
label
Variation of circulating tumor ...... and therapeutic implications.
@en
Variation of circulating tumor ...... and therapeutic implications.
@nl
prefLabel
Variation of circulating tumor ...... and therapeutic implications.
@en
Variation of circulating tumor ...... and therapeutic implications.
@nl
P2093
P356
P1433
P1476
Variation of circulating tumor ...... and therapeutic implications.
@en
P2093
A Goldhirsch
I Minchella
M Salvatici
P304
P356
10.1093/ANNONC/MDM558
P577
2007-12-04T00:00:00Z